Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

ML390

Copy Product Info
🥰Excellent
Catalog No. T13774Cas No. 2029049-79-2

ML390 exerts its potent differentiation effect on multiple leukemia models.

ML390

ML390

Copy Product Info
🥰Excellent
Purity: 99.76%
Catalog No. T13774Cas No. 2029049-79-2
ML390 exerts its potent differentiation effect on multiple leukemia models.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
10 mg$41In StockIn Stock
25 mg$73In StockIn Stock
50 mg$113In StockIn Stock
100 mg$202In StockIn Stock
1 mL x 10 mM (in DMSO)$30In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.76%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

ML390 AI Summary
ML390 demonstrates notable cytotoxicity in HEK293 and A549 cell lines, with AC50 values of 6210.0 nM and 26000.0 nM, respectively. It also promotes myeloid differentiation in THP1 and U937 cells, evidenced by an EC50 value of 2070.0 nM. The compound has been shown to induce differentiation in bone marrow cells, U937 cells, and THP1 cells through the upregulation of specific markers. It is soluble in PBS at pH 7.4 and exhibits high plasma protein binding capacity (99.0%) in both mouse and human plasma. Additionally, ML390 inhibits human recombinant DHODH with an IC50 value of 560.0 nM. In the context of antiviral activity, it inhibits SARS-CoV-2 3CL-Pro protease by 9.83% at a concentration of 20 µM and reduces SARS-CoV-2 induced cytotoxicity in VERO-6 cells by 1.65% at a 10 µM concentration after 48 hours of exposure to 0.01 MOI SARS-CoV-2 virus, as measured by high content imaging..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
ML390 exerts its potent differentiation effect on multiple leukemia models.
Chemical Properties
Molecular Weight406.4
FormulaC21H21F3N2O3
Cas No.2029049-79-2
SmilesFC(F)(F)Oc1ccc(cc1)C(=O)NCCC(=O)N[C@@H]1CCCc2ccccc12
Relative Density.1.31 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 27 mg/mL (66.44 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4606 mL12.3031 mL24.6063 mL123.0315 mL
5 mM0.4921 mL2.4606 mL4.9213 mL24.6063 mL
10 mM0.2461 mL1.2303 mL2.4606 mL12.3031 mL
20 mM0.1230 mL0.6152 mL1.2303 mL6.1516 mL
50 mM0.0492 mL0.2461 mL0.4921 mL2.4606 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy ML390 | purchase ML390 | ML390 cost | order ML390 | ML390 chemical structure | ML390 formula | ML390 molecular weight